A detailed history of Capital Research Global Investors transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 33,205,581 shares of ABBV stock, worth $5.98 Billion. This represents 1.42% of its overall portfolio holdings.

Number of Shares
33,205,581
Previous 33,185,394 0.06%
Holding current value
$5.98 Billion
Previous $5.69 Billion 15.21%
% of portfolio
1.42%
Previous 1.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $3.31 Million - $4.02 Million
20,187 Added 0.06%
33,205,581 $6.56 Billion
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $293 Million - $342 Million
1,890,244 Added 6.04%
33,185,394 $5.69 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $159 Million - $181 Million
992,496 Added 3.28%
31,295,150 $5.7 Billion
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $230 Million - $259 Million
-1,673,490 Reduced 5.23%
30,302,654 $4.7 Billion
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $76.1 Million - $88.1 Million
-569,378 Reduced 1.75%
31,976,144 $4.77 Billion
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $420 Million - $523 Million
-3,168,845 Reduced 8.87%
32,545,522 $4.38 Billion
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $144 Million - $166 Million
-997,422 Reduced 2.72%
35,714,367 $5.69 Billion
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $71.7 Million - $86 Million
518,687 Added 1.43%
36,711,789 $5.94 Billion
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.33 Billion - $1.52 Billion
9,896,885 Added 37.64%
36,193,102 $4.86 Billion
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $1.27 Billion - $1.61 Billion
9,216,006 Added 53.96%
26,296,217 $4.03 Billion
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $122 Million - $152 Million
-925,618 Reduced 5.14%
17,080,211 $2.77 Billion
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $108 Million - $136 Million
-1,004,082 Reduced 5.28%
18,005,829 $2.44 Billion
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $34.5 Million - $39.2 Million
324,445 Added 1.74%
19,009,911 $2.05 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $162 Million - $180 Million
-1,535,173 Reduced 7.59%
18,685,466 $2.1 Billion
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $1.81 Billion - $1.99 Billion
-17,700,423 Reduced 46.68%
20,220,639 $2.19 Billion
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $232 Million - $313 Million
-2,883,051 Reduced 7.07%
37,921,062 $4.06 Billion
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $455 Million - $534 Million
-5,299,576 Reduced 11.49%
40,804,113 $3.57 Billion
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $230 Million - $307 Million
-3,128,616 Reduced 6.35%
46,103,689 $4.53 Billion
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $2.41 Billion - $3.65 Billion
-37,370,388 Reduced 43.15%
49,232,305 $3.75 Billion
Q4 2019

Feb 18, 2020

SELL
$72.13 - $90.25 $1.01 Billion - $1.26 Billion
-14,011,979 Reduced 13.93%
86,602,693 $7.67 Billion
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $599 Million - $720 Million
-9,509,347 Reduced 8.64%
100,614,672 $7.62 Billion
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $2.39 Billion - $3.06 Billion
-36,384,326 Reduced 24.83%
110,124,019 $8.01 Billion
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $2.09 Billion - $2.46 Billion
-27,059,898 Reduced 15.59%
146,508,345 $11.8 Billion
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $200 Million - $247 Million
-2,571,964 Reduced 1.46%
173,568,243 $16 Billion
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1.57 Billion - $1.74 Billion
-17,628,648 Reduced 9.1%
176,140,207 $16.7 Billion
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $61.6 Million - $72.9 Million
686,114 Added 0.36%
193,768,855 $18 Billion
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $6.62 Million - $8.87 Million
71,968 Added 0.04%
193,082,741 $18.3 Billion
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $358 Million - $392 Million
3,995,594 Added 2.11%
193,010,773 $18.7 Billion
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $13.2 Billion - $16.9 Billion
189,015,179
189,015,179 $16.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.